Jordan J. Green, PhD

Research Interests

Dr. Green’s Biomaterials and Drug Delivery Laboratory is interested in biomaterials, drug delivery, gene therapy, nanobiotechnology, and cell engineering. Research findings — and the technologies developed — are applied in the fields of ophthalmology, oncology, and regenerative medicine.

The lab works within the chemistry/biology/engineering interface to answer fundamental scientific questions, and to create innovative technologies and therapeutics that can directly benefit human health.

Current projects include:

1. Development of safe and effective biodegradable nanoparticles for DNA and siRNA delivery to treat cancer
2. Polymeric microparticle-based biological treatments for age-related macular degeneration
3. Design of biomimetic artificial antigen presenting cells for immunoengineering
4. Enabling technologies for tissue engineering and regenerative medicine

Titles

• Professor, Biomedical Engineering
• Director, Biomedical Engineering Undergraduate Program
• Professor, Ophthalmology
• Professor, Oncology
• Professor, Neurosurgery
• Professor, Materials Science & Engineering
• Professor, Chemical & Biomolecular Engineering

Affiliated Centers & Institutes

• Institute for Basic Biomedical Science
• Translational Tissue Engineering Center

Education

• PhD, Biological Engineering, Massachusetts Institute of Technology, 2007
• BS, Chemical Engineering, Biomedical Engineering, Carnegie Mellon University, 2003

Recent Highlights

January 21, 2022

Tissue Engineering: The Future is Here

Through advances in biomaterials, stem cell science, and more, researchers are moving tantalizingly close to regenerating damaged body parts, creating new organs, and equipping our existing tissues to fight off debilitating diseases.

• January 6, 2022
  New Color-Coded Test Quickly Reveals If Medical Nanoparticles Deliver Their Payload
  Johns Hopkins Medicine researchers have developed a color-coded test that quickly signals whether newly developed nanoparticles deliver their cargo into target cells.
• December 20, 2021
  News Brief: Jordan Green elected a Fellow of the National Academy of Inventors
  Jordan Green has been elected a Fellow of the National Academy of Inventors, a distinction that honors academic inventors who have created or facilitated outstanding inventions that have had an impact on society.
• July 9, 2020
  Scientists use nanoparticle-delivered gene therapy to inhibit blinding eye disease in rodents
  In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an ophthalmologist — report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

Media